These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1637257)

  • 21. Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism.
    Steinbrecher UP; Witztum JL; Kesaniemi YA; Elam RL
    J Clin Invest; 1983 Apr; 71(4):960-4. PubMed ID: 6300195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of lovastatin therapy on guinea pig low density lipoprotein composition and metabolism.
    Berglund L; Sharkey MF; Elam RL; Witztum JL
    J Lipid Res; 1989 Oct; 30(10):1591-600. PubMed ID: 2614261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the mechanism of action of probucol.
    Steinberg D
    Am J Cardiol; 1986 Jun; 57(16):16H-21H. PubMed ID: 3728306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of long-term administration of probucol on triglyceride turnover in rats.
    Yoshino G; Matsushita M; Maeda E; Nagata K; Naka Y; Murata Y; Hirano T; Kazumi T
    Coron Artery Dis; 1994 Jan; 5(1):67-72. PubMed ID: 8136934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.
    Fruebis J; Steinberg D; Dresel HA; Carew TE
    J Clin Invest; 1994 Jul; 94(1):392-8. PubMed ID: 8040279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probucol protects low-density lipoproteins from in vitro and in vivo oxidation.
    Bittolo-Bon G; Cazzolato G; Avogaro P
    Pharmacol Res; 1994; 29(4):337-44. PubMed ID: 7971685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic modification of low-density lipoproteins in normal and hypercholesterolaemic guinea pigs.
    Weech PK; Mills GL
    Biochem J; 1978 Nov; 175(2):413-9. PubMed ID: 217339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of the receptor pathway to low density lipoprotein catabolism in humans. New methods for quantitation.
    Slater HR; McKinney L; Packard CJ; Shepherd J
    Arteriosclerosis; 1984; 4(6):604-13. PubMed ID: 6439178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low density lipoprotein kinetics in African Green monkeys showing variable cholesterolaemic responses to diets realistic for westernised people.
    Weight MJ; Benade AJ; Lombard CJ; Fincham JE; Marais M; Dando B; Seier JV; Kritchevsky D
    Atherosclerosis; 1988 Sep; 73(1):1-11. PubMed ID: 3178927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural changes in oxidised low-density lipoproteins and of the effect of the anti-atherosclerotic drug probucol observed by synchrotron X-ray and neutron solution scattering.
    Bellamy MF; Nealis AS; Aitken JW; Bruckdorfer KR; Perkins SJ
    Eur J Biochem; 1989 Aug; 183(2):321-9. PubMed ID: 2759086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probucol prevents lipid storage in macrophages.
    Yamamoto A; Takaichi S; Hara H; Nishikawa O; Yokoyama S; Yamamura T; Yamaguchi T
    Atherosclerosis; 1986 Dec; 62(3):209-17. PubMed ID: 3801087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of receptor-independent metabolism of low-density lipoprotein. An application of glycosylated low-density lipoprotein.
    Sasaki J; Okamura T; Cottam GL
    Eur J Biochem; 1983 Apr; 131(3):535-8. PubMed ID: 6301812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-density lipoprotein metabolism in rats treated with cyclosporine.
    López-Miranda J; Vilella E; Pérez-Jiménez F; Espino A; Jiménez-Perepérez JA; Masana L; Turner PR
    Metabolism; 1993 Jun; 42(6):678-83. PubMed ID: 8510510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probucol enhances cholesterol efflux from cultured human skin fibroblasts.
    Goldberg RB; Mendez A
    Am J Cardiol; 1988 Jul; 62(3):57B-59B. PubMed ID: 3394653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the low density lipoprotein receptor in penetration of low density lipoprotein into rabbit aortic wall.
    Wiklund O; Carew TE; Steinberg D
    Arteriosclerosis; 1985; 5(2):135-41. PubMed ID: 3977773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Internalization of low-density-lipoprotein-specific receptors in leukemic guinea pig lymphocytes.
    Sainte-Marie J; Vidal M; Philippot JR; Bienvenue A
    Eur J Biochem; 1986 Aug; 158(3):569-74. PubMed ID: 3732284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein.
    Kesaniemi YA; Witztum JL; Steinbrecher UP
    J Clin Invest; 1983 Apr; 71(4):950-9. PubMed ID: 6300194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.
    Steinbrecher UP; Witztum JL
    Diabetes; 1984 Feb; 33(2):130-4. PubMed ID: 6420216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probucol pretreatment enhances the chemotaxis of mouse peritoneal macrophages.
    Hara S; Nagano Y; Sasada M; Kita T
    Arterioscler Thromb; 1992 May; 12(5):593-600. PubMed ID: 1576120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of low density lipoprotein receptors in freshly isolated leukemic guinea pig lymphocytes (L2C).
    Sainte-Marie J; Vidal M; Philippot JR; Bienvenüe A
    J Recept Res; 1985; 5(2-3):171-92. PubMed ID: 4032367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.